scholarly journals The Role of Attitudes Toward Medication and Treatment Adherence in the Clinical Response to LAIs: Findings From the STAR Network Depot Study

2021 ◽  
Vol 12 ◽  
Author(s):  
Andrea Aguglia ◽  
Laura Fusar-Poli ◽  
Andrea Amerio ◽  
Valeria Placenti ◽  
Carmen Concerto ◽  
...  

Background: Long-acting injectable (LAI) antipsychotics are efficacious in managing psychotic symptoms in people affected by severe mental disorders, such as schizophrenia and bipolar disorder. The present study aimed to investigate whether attitude toward treatment and treatment adherence represent predictors of symptoms changes over time.Methods: The STAR Network “Depot Study” was a naturalistic, multicenter, observational, prospective study that enrolled people initiating a LAI without restrictions on diagnosis, clinical severity or setting. Participants from 32 Italian centers were assessed at three time points: baseline, 6-month, and 12-month follow-up. Psychopathological symptoms, attitude toward medication and treatment adherence were measured using the Brief Psychiatric Rating Scale (BPRS), the Drug Attitude Inventory (DAI-10) and the Kemp's 7-point scale, respectively. Linear mixed-effects models were used to evaluate whether attitude toward medication and treatment adherence independently predicted symptoms changes over time. Analyses were conducted on the overall sample and then stratified according to the baseline severity (BPRS < 41 or BPRS ≥ 41).Results: We included 461 participants of which 276 were males. The majority of participants had received a primary diagnosis of a schizophrenia spectrum disorder (71.80%) and initiated a treatment with a second-generation LAI (69.63%). BPRS, DAI-10, and Kemp's scale scores improved over time. Six linear regressions—conducted considering the outcome and predictors at baseline, 6-month, and 12-month follow-up independently—showed that both DAI-10 and Kemp's scale negatively associated with BPRS scores at the three considered time points. Linear mixed-effects models conducted on the overall sample did not show any significant association between attitude toward medication or treatment adherence and changes in psychiatric symptoms over time. However, after stratification according to baseline severity, we found that both DAI-10 and Kemp's scale negatively predicted changes in BPRS scores at 12-month follow-up regardless of baseline severity. The association at 6-month follow-up was confirmed only in the group with moderate or severe symptoms at baseline.Conclusion: Our findings corroborate the importance of improving the quality of relationship between clinicians and patients. Shared decision making and thorough discussions about benefits and side effects may improve the outcome in patients with severe mental disorders.

2019 ◽  
Vol 14 (12) ◽  
pp. 1711-1718 ◽  
Author(s):  
Jeffrey M. Saland ◽  
Juan C. Kupferman ◽  
Christopher B. Pierce ◽  
Joseph T. Flynn ◽  
Mark M. Mitsnefes ◽  
...  

Background and objectivesDyslipidemia, a risk factor for cardiovascular disease, is common in CKD but its change over time and how that change is influenced by concurrent progression of CKD have not been previously described.Design, setting, participants, & measurementsIn the CKD in Children study we prospectively followed children with progressive CKD and utilized multivariable, linear mixed-effects models to quantify the longitudinal relationship between within-subject changes in lipid measures (HDL cholesterol, non-HDL cholesterol, triglycerides) and within-subject changes in GFR, proteinuria, and body mass index (BMI).ResultsA total of 508 children (76% nonglomerular CKD, 24% glomerular CKD) had 2–6 lipid measurements each, with a median follow-up time of 4 (interquartile range [IQR], 2.1–6.0) years. Among children with nonglomerular CKD, dyslipidemia was common at baseline (35%) and increased significantly as children aged; 43% of children with glomerular CKD had dyslipidemia at baseline and demonstrated persistent levels as they aged. Longitudinal increases in proteinuria were independently associated with significant concomitant increases in non-HDL cholesterol (nonglomerular: 4.9 [IQR, 3.4–6.4] mg/dl; glomerular: 8.5 [IQR, 6.0–11.1] mg/dl) and triglycerides (nonglomerular: 3% [IQR, 0.8%–6%]; glomerular: 5% [IQR, 0.6%–9%]). Decreases in GFR over follow-up were significantly associated with concomitant decreases of HDL cholesterol in children with nonglomerular CKD (−1.2 mg/dl; IQR, −2.1 to −0.4 mg/dl) and increases of non-HDL cholesterol in children with glomerular CKD (3.9 mg/dl; IQR, 1.4–6.5 mg/dl). The effects of increased BMI also affected multiple lipid changes over time. Collectively, glomerular CKD displayed stronger, deleterious associations between within-subject change in non-HDL cholesterol (9 mg/dl versus 1.2 mg/dl; P<0.001) and triglycerides (14% versus 3%; P=0.004), and within-subject change in BMI; similar but quantitatively smaller differences between the two types of CKD were noted for associations of within-subject change in lipids to within-subject change in GFR and proteinuria.ConclusionsDyslipidemia is a common and persistent complication in children with CKD and it worsens in proportion to declining GFR, worsening proteinuria, and increasing BMI.


2021 ◽  
pp. 10.1212/CPJ.0000000000001033
Author(s):  
Tina Duong ◽  
Connie Wolford ◽  
Michael P. McDermott ◽  
Chelsea E. Macpherson ◽  
Amy Pasternak ◽  
...  

Abstract:Purpose To determine change in motor function after treatment with nusinersen in adults with spinal muscular atrophy (SMA) during the first two years of commercial availability.Recent Findings All forty-two adult SMA patients (mean age: 34 years, range 17-66) receiving nusinersen at PNCR sites were assessed for a mean of 12.5 months (range 3-24 months). Data collected prospectively generated a mean annual rate of change over time determined using linear mixed effects models. Motor and ventilatory measures showed positive changes distinct from the progressive decline expected in untreated adults. All participants tolerated nusinersen with normal surveillance labs and no significant adverse events.Summary Trends of improvement in functional motor, patient-reported, and ventilatory measures, suggested nusinersen benefit in adults with SMA, including the chronic, weaker phenotype. Longer duration and larger studies are needed to more firmly establish nusinersen efficacy in adults with SMA.


2018 ◽  
Vol 34 (4) ◽  
pp. 561-566 ◽  
Author(s):  
Cynthia J Janmaat ◽  
Merel van Diepen ◽  
Roula Tsonaka ◽  
Kitty J Jager ◽  
Carmine Zoccali ◽  
...  

2021 ◽  
Author(s):  
Ana Clemente ◽  
Marcus Thomas Pearce ◽  
Marcos Nadal

Empirical aesthetics has mainly focused on general and simple relations between stimulus features and aesthetic appreciation. Consequently, to explain why people differ so much in what they like and prefer continues to be a challenge for the field. One possible reason is that people differ in their aesthetic sensitivity, i.e., the extent to which they weigh certain stimulus features. Studies have shown that people vary substantially in their aesthetic sensitivities to visual balance, contour, symmetry, and complexity, and that this variation explains why people like different things. Our goal here was to extend this line of research to music and examine aesthetic sensitivity to musical balance, contour, symmetry, and complexity. Forty-eight non-musicians rated their liking for 96 4-second Western tonal musical motifs, arranged in four subsets varying in balance, contour, symmetry, or complexity. We used linear mixed-effects models to estimate individual differences in the extent to which each musical attribute determined their liking. The results showed that participants differed remarkably in the extent to which their liking was explained by musical balance, contour, symmetry, and complexity. Furthermore, a retest after two weeks showed that this measure of aesthetic sensitivity is reliable, and suggests that aesthetic sensitivity is a stable personal trait. Finally, cluster analyses revealed that participants divided into two groups with different aesthetic sensitivity profiles, which were also largely stable over time. These results shed light on aesthetic sensitivity to musical content and are discussed in relation to comparable existing research in empirical aesthetics.


Author(s):  
Lisa Vork ◽  
John Penders ◽  
Jonna Jalanka ◽  
Svetlana Bojic ◽  
Sander M. J. van Kuijk ◽  
...  

IntroductionStool consistency has been associated with fecal microbial composition. Stool consistency often varies over time, in subjects with and without gastrointestinal disorders, raising the question whether variability in the microbial composition should be considered in microbiota studies. We evaluated within-subject day-to-day variability in stool consistency and the association with the fecal microbiota in irritable bowel syndrome (IBS) and healthy subjects, over seven days.MethodsTwelve IBS patients and 12 healthy subjects collected fecal samples during seven consecutive days. Stool consistency was determined by the patient-reported Bristol Stool Scale (BSS) and fecal dry weight percentage. 16S rRNA V4 gene sequencing was performed and microbial richness (alpha diversity; Chao1 index, observed number of species, effective Shannon index) and microbial community structure (beta diversity; Bray-Curtis distance, generalized UniFrac, and taxa abundance on family level) were determined.ResultsLinear mixed-effects models showed significant associations between stool consistency and microbial richness, but no time effect. This implies that between-subject but not within-subject variation in microbiota over time can partially be explained by variation in stool consistency. Redundancy analysis showed a significant association between stool consistency and microbial community structure, but additional linear mixed-effects models did not demonstrate a time effect on this.ConclusionThis study supports an association between stool consistency and fecal microbiota, but no effect of day-to-day fluctuations in stool consistency within seven days. This consolidates the importance of considering stool consistency in gut microbiota research, though confirms the validity of single fecal sampling to represent an individual’s microbiota at a given time point. NCT00775060.


2021 ◽  
Vol 95 (4) ◽  
pp. 1517-1520
Author(s):  
Fabian Beier ◽  
Andre Esser ◽  
Lucia Vankann ◽  
Anne Abels ◽  
Thomas Schettgen ◽  
...  

AbstractWe recently demonstrated a significant shortening of age-adapted telomere length (TL) in lymphocytes of polychlorinated biphenyls (PCB)-exposed individuals. Here, we analyzed TL in individuals of the same PCB-exposed cohort during a 6-year follow-up period, investigating the change in TL between the first and second measurement as a function of time, concentration of PCBs and cytomegalovirus (CMV) infection. The age-adjusted TL of lymphocytes within the cohort of PCB-exposed individuals recovered from a first assessment in 2011 to a second assessment in 2017. Remarkably, if the concentration of lower chlorinated PCBs (LC PCBs) in 2011 was high (≥ 0.055 µg/L), the TL of CMV seropositive individuals remained significantly shortened both compared to age-adjusted controls as well as intra individually. This was confirmed by analysis of covariance as well as by multivariate linear mixed effects models. Since telomeres are responsive to various stress response pathways, including viral infection, we conclude that PCBs could contribute to immune senescence-like phenotypes associated with CMV infections and exacerbate negative aspects associated with the aging of the immune system.


2021 ◽  
pp. 001316442199489
Author(s):  
Luyao Peng ◽  
Sandip Sinharay

Wollack et al. (2015) suggested the erasure detection index (EDI) for detecting fraudulent erasures for individual examinees. Wollack and Eckerly (2017) and Sinharay (2018) extended the index of Wollack et al. (2015) to suggest three EDIs for detecting fraudulent erasures at the aggregate or group level. This article follows up on the research of Wollack and Eckerly (2017) and Sinharay (2018) and suggests a new aggregate-level EDI by incorporating the empirical best linear unbiased predictor from the literature of linear mixed-effects models (e.g., McCulloch et al., 2008). A simulation study shows that the new EDI has larger power than the indices of Wollack and Eckerly (2017) and Sinharay (2018). In addition, the new index has satisfactory Type I error rates. A real data example is also included.


Sign in / Sign up

Export Citation Format

Share Document